Introduced to the United States in 2010, Xeomin is an FDA-approved method of treating fine lines and wrinkles. The major difference between Xeomin and Botox is this injectable does not contain a preservation protein and does not need to be refrigerated like Botox, making it easier to distribute since it is a “naked injectable”. This also means patients are less likely to become resistant to the injectable like some patients have reported after multiple injections of Botox.
The injectable works remarkably fast while also releasing the chemical at a steady pace for a longer lasting, smoother skin experience. Patients also report Xeomin allows them more natural facial movement, whereas Botox may cause some to appear “frozen” and look a bit unnatural. Typically, patients receive an injection once every three months to keep up with the effects of the injectable.
Some potential side effects are side effects that are common with all injectables: swelling, redness, and bruising or pain at the injection site.